← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2013Last known activity
Dec 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05772676Lead sponsorPhase 4Dec 1, 2022
- NCT05772676Reponsible party - principal investigatorPhase 4Dec 1, 2022
- NCT01875393Overall official - principal investigatorPhase 3May 1, 2013
Details
- Last known activity
- Dec 1, 2022